ArticleFrontiers in immunology2025
Integrated analysis of single-cell and bulk transcriptomes reveals the prognostic value of polyamine metabolism biomarkers and immune microenvironment features in gastric cancer.
Article in Frontiers in immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Gastric cancer (GC) remains a lethal malignancy with limited prognostic biomarkers. Dysregulated polyamine metabolism promotes tumor progression and immune evasion, yet its clinical implications in GC are poorly characterized. Methods: We conducted an integrative analysis using bulk RNA-seq and single-cell RNA-seq data to investigate the prognostic significance of polyamine metabolism-related genes (PMRGs) in GC. A total of 59 PMRGs were curated and used to score cells via AUCell. High- and low-scoring cells were subjected to differential gene expression, enrichment, and pseudotime trajectory analyses. Prognostic modeling was performed using 10 machine learning algorithms across multiple combinations, followed by validation and nomogram construction. Immune infiltration, immune checkpoint expression, cell-cell communication, and immunotherapy response were evaluated. Drug sensitivity and tumor mutational burden (TMB) were analyzed using public pharmacogenomic datasets. Results: Single-cell analysis identified PMRGs-driven heterogeneity across 11 cell types, with fibroblasts and macrophages showing enhanced signaling in high-risk populations. A 13-gene signature was constructed using StepCox and elastic net, achieving robust prognostic performance (Train dataset AUCs: 0.67-0.70; Validation dataset AUCs: 0.64-0.67). High-risk patients exhibited enriched stromal-immune interactions, elevated immune infiltration, higher Tumor Immune Dysfunction and Exclusion (TIDE) scores, and poorer immunotherapy response. Low-risk patients had higher TMB and sensitivity to 5-Fluorouracil, Docetaxel, Doxorubicin and Paclitaxel. Conclusion: Polyamine metabolism shapes both cellular heterogeneity and the immune microenvironment in gastric cancer. Our integrated model may provide potential guidance for prognostic stratification and therapeutic decision-making in clinical oncology.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.